Excellent Results from the DESolve I First-In-Man Study at One Year for Fully Bioresorbable Drug Eluting Coronary Scaffold System Presented Sunnyvale, Calif. – Elixir Medical Corporation, a developer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results